Northwestern Mutual Wealth Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
Other funds holding BCLI
BSB
VWA
SPIA
DJSG
Northwestern Mutual Wealth Management's BCLI Position: Q3 2025 in Review
Northwestern Mutual Wealth Management sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q3 2025, closing a stake of 10 shares — an estimated $11 sold.
Northwestern Mutual Wealth Management first reported a position in BCLI in Q2 2024 and held it in 5 quarters. The position peaked at $55 in Q2 2024. 5 funds tracked by Wall St. Rank hold BCLI as of Q3 2025.
- Northwestern Mutual Wealth Management reported no remaining BRAINSTORM CELL THERAPUTC position as of Q3 2025 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 10 BRAINSTORM CELL THERAPUTC shares in Q3 2025, an estimated $11.
- Northwestern Mutual Wealth Management first reported a position in BRAINSTORM CELL THERAPUTC in Q2 2024 and held it in 5 quarters.
- Northwestern Mutual Wealth Management's BRAINSTORM CELL THERAPUTC position peaked at $55 in Q2 2024.
- 5 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q3 2025.
Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.